Biocon Gets CDSCO Panel Nod to Market Trastuzumab PGS in India Dr. Divya Colin25 Jun 2025 4:51 PM ISTNew Delhi: The Subject Expert Committee (SEC) on Oncology and Hematology, functioning under the Central Drugs Standard Control Organisation (CDSCO),...
Laurus Labs Asked to Submit Justification, Data for Pediatric Darunavir-Ritonavir FDC Proposal Farhat Nasim23 Jun 2025 3:30 PM ISTNew Delhi: The Subject Expert Committee (SEC) on Antimicrobial & Antiviral under the Central Drugs Standard Control Organisation (CDSCO) has asked...
State Drug Alert: CDSCO Flags 128 Batches Including Paracetamol, Dapagliflozin Farhat Nasim22 Jun 2025 3:00 PM ISTNew Delhi: As part of its ongoing quality surveillance efforts, the Central Drugs Standard Control Organisation (CDSCO) has flagged more than 120...
SEC Recommends Market Authorization for Elobixibat 5 mg Tablets by Exemed Pharma Parthika Patel22 Jun 2025 10:00 AM ISTNew Delhi: The Subject Expert Committee (SEC) under the Gastroenterology and Hepatology division of the Central Drugs Standard Control Organization...
AstraZeneca's Oral PCSK9 Inhibitor AZD0780 Cleared for Phase III Trial by CDSCO Panel Dr. Divya Colin22 Jun 2025 9:30 AM ISTNew Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has granted approval to AstraZeneca Pharma...
58 Drug Batches, Including Dexona Fail CDSCO Quality Standards Farhat Nasim21 Jun 2025 8:08 PM ISTNew Delhi: In its continued effort to ensure drug safety and compliance, the Central Drugs Standard Control Organisation (CDSCO) has flagged 58...
Sun Pharma Gets Relief on Packaging Norms for Pantoprazole-Levosulpiride FDC Parthika Patel21 Jun 2025 4:18 PM ISTNew Delhi: In a regulatory relief to the company, the Subject Expert Committee (SEC) under the Gastroenterology and Hepatology division of the Central...
Mankind Pharma Gets CDSCO Panel Nod to Conduct Phase III Trial of Resmetirom Tablets Parthika Patel21 Jun 2025 11:45 AM ISTNew Delhi: The Subject Expert Committee (SEC) under the Gastroenterology and Hepatology division of the Central Drugs Standard Control Organisation...
Zydus Gets CDSCO Panel Nod to Conduct Phase IV Trial for Indacaterol-Budesonide FDC Inhalation Dr. Divya Colin20 Jun 2025 11:45 PM ISTNew Delhi: In response to the proposal presented by Zydus Healthcare, the Subject Expert Committee (SEC) functional under the Central Drug Standard...
CDSCO Panel Rejects Phase II Data for Reliance's RelCoVax COVID-19 Booster Over Immunogenicity Gap Parthika Patel19 Jun 2025 7:53 PM ISTNew Delhi: The Subject Expert Committee (SEC) on COVID-19 vaccines, operating under the Central Drugs Standard Control Organisation (CDSCO), has...
Novo Nordisk Told to Increase Indian Patient Enrollment for Ziltivekimab Study Dr. Divya Colin19 Jun 2025 7:36 PM ISTNew Delhi: In response to a proposal by Novo Nordisk, the Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO)...
Exemed's Sitagliptin FDC Hits Roadblock as CDSCO Panel Flags No Added Safety Benefit Parthika Patel18 Jun 2025 5:53 PM ISTNew Delhi: In a setback for Exemed Pharmaceutical, the Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO)...
